Over the past 12 months, 11 insiders at NEUROCRINE BIOSCIENCES INC filed 24 open-market SEC Form 4 transactions on NBIX: 0 purchases worth $0 and 24 sales worth $77.8M. Insiders have been net sellers over this period. The most recent filing was on Jul 10, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 26 | Ingrid DelaetChief Regulatory Officer | SELL | 4.4K | $181.02 | $791K |
| Jul 9, 26 | Darin LippoldtChief Legal Officer | SELL | 10.0K | $179.60 | $1.8M |
| Jul 9, 26 | Ingrid DelaetChief Regulatory Officer | SELL | 8.4K | $178.72 | $1.5M |
| Jul 8, 26 | Ingrid DelaetChief Regulatory Officer | SELL | 2.7K | $178.54 | $489K |
| Jul 7, 26 | Ingrid DelaetChief Regulatory Officer | SELL | 3.4K | $178.57 | $607K |
| Jun 2, 26 | Julie CookeChief Human Resources Officer | SELL | 14.2K | $158.59 | $2.2M |
| May 29, 26 | Ingrid DelaetChief Regulatory Officer | SELL | 2.3K | $156.71 | $354K |
| May 26, 26 | David W. BoyerChief Corp. Affairs Officer | SELL | 3.9K | $156.64 | $609K |
| May 19, 26 | Kevin Charles Gorman | SELL | 245.1K | $154.33 | $37.8M |
| Jan 16, 26 | Kyle GanoChief Executive Officer | SELL | 34.6K | $132.71 | $4.6M |
| Dec 16, 25 | Leslie Norwalk VDirector | SELL | 1.2K | $155.09 | $185K |
| Dec 15, 25 | Leslie Norwalk VDirector | SELL | 5.0K | $152.23 | $761K |
| Dec 8, 25 | Darin LippoldtChief Legal Officer | SELL | 4.4K | $159.65 | $699K |
| Dec 3, 25 | Gary A LyonsDirector | SELL | 15.0K | $152.61 | $2.3M |
| Nov 28, 25 | Eric BenevichChief Commercial Officer | SELL | 6.0K | $151.74 | $906K |
| Nov 25, 25 | George J MorrowDirector | SELL | 15.0K | $143.37 | $2.2M |
| Nov 5, 25 | William H RastetterDirector | SELL | 18.0K | $151.82 | $2.7M |
| Nov 4, 25 | Kyle GanoChief Executive Officer | SELL | 300 | $141.97 | $43K |
| Aug 7, 25 | Kevin Charles GormanDirector | SELL | 106.3K | $126.41 | $13.4M |
| Jul 10, 25 | Ingrid DelaetChief Regulatory Officer | SELL | 457 | $135.00 | $62K |
| Jul 9, 25 | Jude OnyiaChief Scientific Officer | SELL | 59.8K | $130.46 | $7.8M |
| Jul 2, 25 | Jude OnyiaChief Scientific Officer | SELL | 20.4K | $130.13 | $2.6M |
| May 27, 25 | Kevin Charles GormanDirector | SELL | 9.6K | $120.38 | $1.2M |
| May 5, 25 | William H RastetterDirector | SELL | 30.0K | $110.20 | $3.3M |
| Feb 14, 25 | Eiry RobertsChief Medical Officer | SELL | 500 | $115.04 | $58K |
| Feb 13, 25 | Kevin Charles GormanDirector | SELL | 3.0K | $116.69 | $351K |
| Feb 13, 25 | Stephen A SherwinDirector | SELL | 13.8K | $116.69 | $1.6M |
| Feb 13, 25 | Matt AbernethyChief Financial Officer | SELL | 1.4K | $116.87 | $158K |
| Feb 13, 25 | Eric BenevichChief Commercial Officer | SELL | 1.1K | $116.74 | $128K |
| Feb 13, 25 | David W. BoyerChief Corp. Affairs Officer | SELL | 955 | $116.79 | $112K |
| Feb 13, 25 | Julie CookeChief Human Resources Officer | SELL | 796 | $116.80 | $93K |
| Feb 13, 25 | Ingrid DelaetChief Regulatory Officer | SELL | 755 | $116.72 | $88K |
| Feb 13, 25 | Kyle GanoChief Executive Officer | SELL | 1.4K | $116.86 | $158K |
| Feb 13, 25 | Darin LippoldtChief Legal Officer | SELL | 1.1K | $116.76 | $128K |
| Feb 13, 25 | Jude OnyiaChief Scientific Officer | SELL | 1.4K | $116.83 | $169K |
| Feb 13, 25 | Eiry RobertsChief Medical Officer | SELL | 1.1K | $116.90 | $130K |
| Feb 10, 25 | Matt AbernethyChief Financial Officer | SELL | 980 | $118.27 | $116K |
| Feb 10, 25 | Eric BenevichChief Commercial Officer | SELL | 980 | $118.31 | $116K |
| Feb 10, 25 | David W. BoyerChief Corp. Affairs Officer | SELL | 700 | $118.31 | $83K |
| Feb 10, 25 | Julie CookeChief Human Resources Officer | SELL | 700 | $118.28 | $83K |
| Feb 10, 25 | Kevin Charles GormanDirector | SELL | 2.3K | $118.37 | $269K |
| Feb 10, 25 | Kyle GanoChief Executive Officer | SELL | 980 | $118.39 | $116K |
| Feb 10, 25 | Darin LippoldtChief Legal Officer | SELL | 911 | $118.25 | $108K |
| Feb 10, 25 | Eiry RobertsChief Medical Officer | SELL | 980 | $118.22 | $116K |
| Feb 3, 25 | Ingrid DelaetChief Regulatory Officer | SELL | 623 | $149.29 | $93K |
| Jan 31, 25 | Matt AbernethyChief Financial Officer | SELL | 1.3K | $152.87 | $196K |
| Jan 31, 25 | Eric BenevichChief Commercial Officer | SELL | 1.2K | $152.94 | $185K |
| Jan 31, 25 | David W. BoyerChief Corp. Affairs Officer | SELL | 1.1K | $152.94 | $169K |
| Jan 31, 25 | Julie CookeChief Human Resources Officer | SELL | 916 | $152.89 | $140K |
| Jan 31, 25 | Ingrid DelaetChief Regulatory Officer | SELL | 422 | $153.05 | $65K |
Over the past 12 months, insiders at NEUROCRINE BIOSCIENCES INC filed 0 open-market purchases worth $0 and 24 sales worth $77.8M on NBIX, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 10, 26.
11 different insiders at NEUROCRINE BIOSCIENCES INC filed open-market SEC Form 4 transactions on NBIX over the last 12 months.
InsiderTape plots every NBIX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every NEUROCRINE BIOSCIENCES INC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →